We assessed the discontinuation rate and the reason for discontinuation of common contraceptives used by reproductive-aged Thai women. We recruited 1880 women aged 18–45 years from the Family Planning Clinic of the Chulalongkorn Hospital in Bangkok. The participants were followed at three, six and twelve months. A Cox proportional hazards model was used to determine personal risks of discontinuing contraceptives. The incidence rate for discontinuation of combined oral contraceptive pills (COCs), depot medroxyprogesterone acetate (DMPA), copper intrauterine device (IUD), and contraceptive implant(s) were 21.3, 9.2, 4.4, and 2.3/100 person-years, respectively. Most of the women who discontinued (185/222) discontinued contraceptives due to side effects. Compared to contraceptive implant users, the adjusted hazard ratios (aHRs) [95% confidence intervals (CIs)] of discontinuing COCs, DMPA, and the copper IUD were 9.6 (4.3–21.8), 4.2 (1.8–10.0), and 2.2 (0.8–5.9), respectively. Lower income, higher parity, history of miscarriage, and history of abortion were independent predictors of contraceptive discontinuation in a multivariable model.
The aim of this study was to predict the timing of delivery within seven days in singleton pregnant women with threatened preterm labour and preterm labour by using a three-dimensional (3D) ultrasound measurement of foetal adrenal gland volume enlargement, a foetal zone enlargement and cervicovaginal placental alpha microglobulin-1 (PAMG-1) test. This prospective cohort study included singleton pregnant women at 22-36 weeks of gestation who presented with threatened preterm labour and with preterm labour. Transabdominal 3D ultrasound measurement of the whole foetal adrenal gland and of the foetal adrenal zone were performed. Qualitative cervicovaginal PAMG-1 detection was performed at the same time. One hundred and fifty-four pregnant women were included into the study. Eighty-four pregnant women had threatened preterm labour and seventy pregnant women had preterm labour. Twenty-nine pregnant women (18%) delivered within seven days. Use of foetal adrenal gland volume enlargement, foetal zone enlargement and the PAMG-1 test in combination increased sensitivity; if one parameter was positive, the sensitivity, specificity, positive predictive value and negative predictive value were 82.8%, 27.2%, 20.9% and 87.2%, respectively, in the prediction of the timing of delivery within seven days. The combination of foetal adrenal gland enlargement and PAMG-1 increased sensitivity for the prediction of the timing of delivery within seven days in pregnant women presenting with threatened preterm labour and preterm labour. Impact Statement What is already known on this subject? An increased foetal adrenal gland volume is significantly correlated with the risk of preterm birth. What do the results of this study add? The combination of a foetal adrenal gland enlargement and a placental alpha microglobulin-1 increased sensitivity for the prediction of the timing of delivery within seven days in pregnant women presenting with threatened preterm labour and preterm labour. What are the implications of these findings for clinical practice and/or further research? The combination of a foetal adrenal gland enlargement and placental alpha microglobulin-1 may be used for the prediction of the timing of delivery within seven days in pregnant women presenting with threatened preterm labour and with preterm labour.
BackgroundEven though almost 80% of sexually active Thai women use modern contraceptives, yet unintended pregnancy remains a significant reproductive health issue. One possible explanation is that the women do not use contraceptives or stopped using contraceptives at some point in their lifetime. At present, there is scant information available about contraceptive discontinuation among Thai women. We assessed the discontinuation rate and the reason for discontinuation of the four most common contraceptives used by reproductive aged Thai women: combined oral contraceptive pills (COCs), depot medroxyprogesterone acetate (DMPA), copper IUD, and contraceptive implant(s).MethodsThere were 1,880 women aged 18-45 years recruited from the Family Planning Clinic of the Chulalongkorn Hospital in Bangkok. The participants were followed at months 3, 6 and 12 either by attending the clinic or being interviewed via a phone call. Incidence density and cumulative incidence based on the Kaplan-Meier approach were used to assess contraceptive discontinuation. Cox proportional hazards model was used to determine significant personal risks of discontinuing contraceptive.ResultsAmong all, 839 (44.6%) women initiated COCs; 494 (26.3%) initiated DMPA; 280 (14.9%) initiated copper IUD and 267 (14.2%) initiated contraceptive implant(s). The incidence density for discontinuation of COCs, DMPA, copper IUD, and contraceptive implant(s) were 21.33, 9.21, 4.36, and 2.26 / 100 person-year, respectively. Most of the women (185/222) discontinued their contraceptives because of the side effects. Compared to the contraceptive implant(s) users, adjusted HR (95% CI) of discontinuing COCs, DMPA, and copper IUD were 9.92 (4.38-22.46), 4.25 (1.81-9.98), 2.16 (0.81-5.76), respectively. Lower-income, higher parity numbers, history of miscarriage, and history of abortion were independent predictors of contraceptive discontinuation in a multivariable model.ConclusionsThe discontinuation rate of COCs, the most popular contraceptive method for Thai women, was the highest during the one-year period of the study. The primary reason for discontinuing the use of the various contraceptive methods was the side effects.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.